You have 9 free searches left this month | for more free features.

B-cell malignancy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed or Refractory B-cell Malignancy(NHL/ALL) Trial in Luoyang (ET-02)

Recruiting
  • Relapsed or Refractory B-cell Malignancy(NHL/ALL)
  • ET-02
  • Luoyang, Henan, China
    •The First Affiliated Hospital of Henan University of Science an
Aug 26, 2021

B-cell Malignancy Trial in Sanhe (CD19-CAR-T cells)

Completed
  • B-cell Malignancy
  • CD19-CAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 28, 2022

B Cell Malignancy Trial in Sanhe (CD19-STAR-T cells)

Completed
  • B Cell Malignancy
  • CD19-STAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 28, 2022

B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

Not yet recruiting
  • B-cell Malignancy
  • +7 more
  • (no location specified)
Oct 26, 2022

B Cell Malignancy Trial in Hefei, Suzhou (ThisCART19 cells)

Recruiting
  • B Cell Malignancy
  • ThisCART19 cells
  • Hefei, Anhui, China
  • +1 more
Dec 20, 2021

B-cell Malignancy Trial in Xuzhou (ThisCART22 cells)

Recruiting
  • B-cell Malignancy
  • ThisCART22 cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Nov 9, 2021

B-cell Malignancy Trial in Xuzhou (ThisCART19 cells)

Recruiting
  • B-cell Malignancy
  • ThisCART19 cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Oct 25, 2021

B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

Recruiting
  • B-cell Malignancy, Low-grade
  • +4 more
  • Beijing, Beijing, China
  • +8 more
Jul 20, 2022

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

Enrolling by invitation
  • Monoclonal Gammopathy of Undetermined Significance
  • +6 more
    • Milwaukee, Wisconsin
      Aurora Health Care
    Jul 20, 2021

    B-cell Malignancy, B-cell Lymphoma, B-Cell Acute Lymphoblastic Leukaemia Trial in Shanghai (CD19 CAR T)

    Recruiting
    • B-cell Malignancy
    • +2 more
    • CD19 CAR T
    • Shanghai, China
      Shanghai Tong Ren hospital
    Nov 3, 2020

    B Cell Malignancy Trial in Hefei (ThisCART22 cells injection)

    Recruiting
    • B Cell Malignancy
    • ThisCART22 cells injection
    • Hefei, Anhui, China
      The First Affiliated Hospital of USTC (Anhui Provincial Hospital
    Nov 27, 2020

    B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

    Completed
    • B-cell Lymphoma
    • +2 more
    • BI-1206 single agent dose escalation phase
    • +3 more
    • Leicester, England, United Kingdom
    • +4 more
    Jun 17, 2021

    B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

    Recruiting
    • B-Cell Lymphoid Malignancies
    • +2 more
    • Hematopoietic Stem Cells from HLA-compatible Related
    • Hematopoietic Stem Cells from HLA Unrelated
    • Miami, Florida
      Miami Cancer Institute at Baptist Health of South Florida
    May 5, 2022

    Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma Trial in Hangzhou (CTA101)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Non-hodgkin Lymphoma
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Dec 24, 2020

    B-Cell Reconstitution After Hematopoietic Stem Cell

    Not yet recruiting
    • Hematologic Malignancy
      • (no location specified)
      Dec 18, 2020

      CB-Long-Term Safety Study (CB-LTSS)

      Enrolling by invitation
      • Lymphoma, Non-Hodgkin
      • +7 more
      • Allogeneic CAR-T therapy
      • Irvine, California
      • +3 more
      Apr 14, 2022

      Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

      Active, not recruiting
      • Hodgkin's Lymphoma
      • +17 more
      • mycophenolate mofetil
      • +2 more
      • Richmond, Virginia
        Virginia Commonwealth University/Massey Cancer Center
      Dec 21, 2021

      Hematologic Malignancy, Leukemia, Lymphoma Trial in Boston (CAR-37 T cells)

      Recruiting
      • Hematologic Malignancy
      • +5 more
      • CAR-37 T cells
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Oct 28, 2021

      Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

      Terminated
      • Leukemia, Myeloid, Chronic
      • +8 more
      • Stem Cell Transplant
      • +5 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Dec 31, 2020

      Leukemia, Lymphocytic, Chronic, B-Cell Trial in Poland, Spain (Ibrutinib, OC: Ethinylestradiol (EE) 30 mcg and Levonorgestrel

      Completed
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Krakow, Poland
      • +3 more
      Dec 3, 2019

      Lymphoma, B-Cell, Leukemia, B-cell Trial in Nanjin (chimeric antigen receptor T cells)

      Unknown status
      • Lymphoma, B-Cell
      • Leukemia, B-cell
      • chimeric antigen receptor T cells
      • Nanjin, Jiangsu, China
        Department of Haematology, the First Affiliated Hospital of Nanj
      Aug 5, 2019

      Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Hangzhou (CT-RD06)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Non-Hodgkin's Lymphoma
      • CT-RD06
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      Feb 19, 2020

      Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (ATIR101, Haploidentical

      Completed
      • Acute Myeloid Leukemia
      • +2 more
      • ATIR101
      • +3 more
      • Brugge, Belgium
      • +10 more
      May 17, 2021

      Critical Care Outcomes of Hematologic Oncology Patients

      Active, not recruiting
      • Hematologic Malignancy
      • Stem Cell Transplant
        • Calgary, Alberta, Canada
        • +12 more
        Sep 3, 2021